Novaferon for COVID-19 Treatment Trial (NCTT-005)
NCT04708158 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 385
Last updated 2022-01-28
Summary
A multicenter, randomized, double-blind, placebo-controlled trial for hospitalized moderate COVID-19 patients
Conditions
- Covid19
Interventions
- BIOLOGICAL
-
Novaferon
a novel recombinant antiviral protein drug
- BIOLOGICAL
-
Saline
Sponsors & Collaborators
-
Genova Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-25
- Primary Completion
- 2023-04-30
- Completion
- 2023-04-30
Countries
- Japan
Study Locations
More Related Trials
-
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)
NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts
NCT05415241 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019
NCT04310228 ·Status: UNKNOWN ·Phase: NA
-
A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia
NCT04254874 ·Status: UNKNOWN ·Phase: PHASE4
-
GS-441524 for COVID-19 SAD, FE, and MAD Study in Healthy Subjects
NCT06274853 ·Status: WITHDRAWN ·Phase: PHASE1
-
Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2
NCT05069649 ·Status: COMPLETED ·Phase: PHASE3
-
Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients
NCT04780581 ·Status: TERMINATED ·Phase: PHASE4
-
Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19
NCT04358549 ·Status: COMPLETED ·Phase: PHASE2
-
PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT05780541 ·Status: TERMINATED ·Phase: PHASE3
-
Nitazoxanide Therapy for Patients With COVID-19 Pneumonia
NCT04561219 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)
NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
NCT04758273 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19
NCT06039163 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Confirmatory Study of K-237
NCT05056883 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19
NCT04732949 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients
NCT04449380 ·Status: TERMINATED ·Phase: PHASE2
-
Early Intervention in COVID-19: Favipiravir Verses Standard Care
NCT04373733 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy
NCT04412252 ·Status: WITHDRAWN ·Phase: PHASE2
-
PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19
NCT04784767 ·Status: COMPLETED ·Phase: PHASE1
-
MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT05780463 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients
NCT05352347 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants
NCT05257798 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Efficacy and Safety of MAS825 in Patients With COVID-19
NCT04382651 ·Status: COMPLETED ·Phase: PHASE2
-
Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure
NCT04244591 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)
NCT04487886 ·Status: COMPLETED ·Phase: PHASE2